| Literature DB >> 28785630 |
Erik M van Oosten1, Alexander H Boag2, Kris Cunningham2, John Veinot3, Andrew Hamilton1,4, Dimitri Petsikas1,4, Darrin Payne1,4, Wilma M Hopman5, Damian P Redfearn1,5, WonJu Song6, Shawn Lamothe6, Shetuan Zhang6, Adrian Baranchuk1,5.
Abstract
BACKGROUND: Obstructive Sleep Apnea (OSA) results in intermittent hypoxia leading to atrial remodeling, which, among other things, facilitates development of atrial fibrillation. While much data exists on the macrostructural changes in cardiac physiology induced by OSA, there is a lack of studies looking for histologic changes in human atrial tissue induced by OSA which might lead to the observed macrostructural changes.Entities:
Keywords: Histological analysis; Human atrial tissue; Myocardial fibrosis; Obstructive Sleep Apnea
Year: 2015 PMID: 28785630 PMCID: PMC5497175 DOI: 10.1016/j.ijcha.2015.01.008
Source DB: PubMed Journal: Int J Cardiol Heart Vasc ISSN: 2352-9067
Demographic Data (OSA: Obstructive Sleep Apnea; BMI: Body Mass Index; COPD: Chronic Obstructive Pulmonary Disease; AF: Atrial Fibrillation; LVEF: Left Ventricular Ejection Fraction; LAD: Left Atrial Diameter; RAV: Right Atrial Volume; RAVI: Right Atrial Volume Index; PCAF: Post-CABG Atrial Fibrillation; CPAP: Continuous Positive Airway Pressure).
| Total | OSA low risk (N = 8) | OSA high risk (N = 10) | ||
|---|---|---|---|---|
| Age (years) | 67.8 | 70.1 ± 6.9 | 66.0 ± 9.2 | 0.316 |
| Gender (% male) | 88.9 | 75 | 100 | 0.183 |
| BMI (kg/m2) | 27.6 | 26.5 ± 2.1 | 28.5 ± 5.4 | 0.337 |
| Smoker (%) | 27.8 | 12.5 | 40 | 0.314 |
| Hypertension (%) | 72.2 | 62.5 | 80 | 0.608 |
| Diabetes (%) | 16.7 | 12.5 | 20 | 1.000 |
| COPD (%) | 5.6 | 0 | 10 | 1.000 |
| Asthma (%) | 11.1 | 25 | 0 | 0.183 |
| History AF (%) | 0 | 0 | 0 | n/a |
| LVEF (%) | 55.4 | 56.8 ± 6.1 | 54.3 ± 8.2 | 0.493 |
| LAD (mm) | 38.8 | 38.1 ± 2.5 | 39.4 ± 4.8 | 0.610 |
| RAV (mL) | 50.4 | 52.3 ± 10.2 | 48.8 ± 15.3 | 0.591 |
| RAVI (mL/m2) | 27.4 | 29.0 ± 4.8 | 26.2 ± 4.0 | 0.180 |
| Beta-blocker use (%) | 61.1 | 75 | 50 | 0.367 |
| Presence of PCAF (%) | 50 | 50 | 50 | 1.000 |
| Length of stay (days) | 5.4 | 6.0 ± 2.1 | 4.9 ± 1.0 | 0.156 |
| CPAP use (%) | 0 | 0 | 0 | n/a |
Histological analysis results (OSA: Obstructive Sleep Apnea).
| Total | OSA low risk (N = 8) | OSA high risk (N = 10) | ||
|---|---|---|---|---|
| Myocytolysis | ||||
| Absent/mild (%) | 5.6 | 0 | 10 | 0.181 |
| Moderate (%) | 83.3 | 75 | 90 | |
| Marked (%) | 11.1 | 25 | 0 | |
| Nuclear hypertrophy | ||||
| Absent/mild (%) | 44.4 | 50 | 40 | 0.671 |
| Moderate (%) | 55.6 | 50 | 60 | |
| Marked (%) | 0 | 0 | 0 | |
| Myocardial inflammation | ||||
| Absent/mild (%) | 100 | 100 | 100 | n/a |
| Moderate (%) | 0 | 0 | 0 | |
| Marked (%) | 0 | 0 | 0 | |
| Presence of amyloid (%) | 0 | 0 | 0 | n/a |
| Presence of thrombus (%) | 0 | 0 | 0 | n/a |
| Sirius Red staining (collagen) | ||||
| Total tissue (% pixels) | 29.8 ± 6.9 | 30.7 ± 5.6 | 29.0 ± 8.0 | 0.619 |
| Myocardium (% pixels) | 21.7 ± 6.6 | 21.2 ± 4.7 | 22.1 ± 8.1 | 0.776 |
Fig. 1Representative routinely stained atrial tissue sections from patients with A. low-risk OSA, with focal myocyte nuclear hypertrophy (arrow), and B. high-risk OSA with focal myocytolysis (arrow). No significant differences were observed. No cases showed more than mild inflammation (hematoxylin and eosin stain, 200 ×).
Fig. 2Example of Sirius Red staining from atrial tissue from patients with A. low-risk OSA and B. high-risk OSA (positive staining at arrow). No significant differences were observed (Sirius red stain, 200 ×).